To compare the detection rates of overall prostate cancer (PCa) and clinically significant PCa (csPCa) and the median percentage of cancer per biopsy core between MRI-guided In-bore and MRI-TRUS fusion-targeted biopsy (TBx).
MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques / Del Monte, Maurizio; Cipollari, Stefano; Del Giudice, Francesco; Pecoraro, Martina; Bicchetti, Marco; Messina, Emanuele; Dehghanpour, Ailin; Ciardi, Antonio; Sciarra, Alessandro; Catalano, Carlo; Panebianco, Valeria. - In: BRITISH JOURNAL OF RADIOLOGY. - ISSN 0007-1285. - 95:1131(2022). [10.1259/bjr.20210528]
MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques
Cipollari, StefanoSecondo
;Del Giudice, Francesco;Pecoraro, Martina;Bicchetti, Marco;Messina, Emanuele;Dehghanpour, Ailin;Ciardi, Antonio;Sciarra, Alessandro;Catalano, CarloPenultimo
;Panebianco, Valeria
Ultimo
2022
Abstract
To compare the detection rates of overall prostate cancer (PCa) and clinically significant PCa (csPCa) and the median percentage of cancer per biopsy core between MRI-guided In-bore and MRI-TRUS fusion-targeted biopsy (TBx).| File | Dimensione | Formato | |
|---|---|---|---|
|
Del-Monte_MRI-directed_2022.pdf
accesso aperto
Note: https://www.birpublications.org/doi/10.1259/bjr.20210528?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub 0pubmed
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.37 MB
Formato
Adobe PDF
|
1.37 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
